Cas:1035235-27-8 tert-Butyl 4-bromoisoindoline-2-carboxylate manufacturer & supplier

Chemical Name:tert-Butyl 4-bromoisoindoline-2-carboxylate

CAS.NO:1035235-27-8

Synonyms:2-Methyl-2-propanyl 4-bromo-1,3-dihydro-2H-isoindole-2-carboxylate;tert-butyl 4-bromo-1,3-dihydroisoindole-2-carboxylate;2H-Isoindole-2-carboxylic acid, 4-bromo-1,3-dihydro-, 1,1-dimethylethyl ester;tert-Butyl 4-bromo-1,3-dihydro-2H-isoindole-2-carboxylate

Molecular Formula:C₁₃H₁₆BrNO₂

Molecular Weight:298.176

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:363.2±42.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.570

PSA:29.54000

Exact Mass:297.036438

LogP:3.22

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Methyl-2-propanyl 4-bromo-1,3-dihydro-2H-isoindole-2-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-Butyl 4-bromo-1,3-dihydro-2H-isoindole-2-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-Butyl 4-bromo-1,3-dihydro-2H-isoindole-2-carboxylate Use and application,2-Methyl-2-propanyl 4-bromo-1,3-dihydro-2H-isoindole-2-carboxylate technical grade,usp/ep/jp grade.

Related News: The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary. (2S,1’S)-2,3-dihydro-2-(1′,2′-dihydroxy-1′-methylethyl)-7H-furo[3,2-g][1]benzopyran-7-one manufacturers Altogether, the IPO added $550 million to the family’s collective fortune, which now stands at an estimated $4.8 billion. L-Proline,L-cysteinyl-L-phenylalanyl-L-valyl-L-arginyl-L-leucyl-L-prolyl-L-prolyl- suppliers The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary. 1-Brom-5-nitro-3-propyloxy-2-(2-diaethylamino-aethoxy)-benzol vendor & factory The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary.,During Covid-19, the company has helped fill a void in meeting API demand for medicines used to treat patients with the virus. In April of last year, Wavelength expanded its production of API for three generic drugs— sedative midazolam, muscle relaxant cisatracurium, and paralytic rocuronium — to help keep up with hospital demand.